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Abstract: Background: Chronic subdural hematomas (CSDHs) are one of the most 
common intracranial lesions treated in a neurosurgical department. They associate 
significant morbidity and mortality that increase in the case of recurrences requiring 
reoperation. Despite extensive published literature, there is still significant debate 
regarding optimal management of CSDHs and their potential recurrence. Objective: 
Identify factors for recurrence requiring reoperation of CSDHs in order to adjust our 
management strategies. Methods: A retrospective review of 64 cases harbouring 71 
CSDHs that were surgically treated in the Neurosurgery Department of “Saint 
Pantelimon” Clinical Emergency Hospital over a period of two years (January 2016 - 
December 2017). Two main surgical techniques were used: small trephine and large 
bone flap craniotomy, according to the operating surgeon’s preference. CT scans were 
performed at admission and 24 hours postoperatively. Postoperative management was 
similar in all cases. Results: Recurrence requiring reoperation (RrR) was encountered in 
16 (25%) of the reviewed cases. Reoperation was found to be significantly more often 
encountered in particular preoperative CT characteristics: laminar type (RrR=38,10%, 
p=0.027) and maximal thickness above 22 mm (43,75%, p = 0,013). Surgical technique 
had a substantial impact on recurrence: in trephinated cases, reoperation was required 
in only 8 of 51 patients (RrR=15,69%, p = 0.007), while large bone flap craniotomy 
associated a RrR of 61,54% (p = 0.008), which increased when associated with inner 
membranectomy (RrR=87,5%, p = 0,007) or subdural drain placement (88,89%, p = 
0.007). Reoperations not only doubled the neurosurgical hospital length of stay, but 
also associated higher perioperative mortality rates (18.75% versus 14,58%). 
Conclusions: In our series, surgical technique had a decisive impact on the rate of 
recurrence. CSDH surgery is another example of “in medio stat virtus”, where finding 
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the right balance between the least and most aggressive technique has the potential of 
providing the best outcomes, and thus small trephination could be taken into 
consideration. 
Key words: chronic subdural hematoma, recurrence requiring reoperation, risk factors, 
small trephination 
 
Introduction 
First described by Swiss pathologist 
Johann Jakob Wepfer  in 1658  in his treatise 
on strokes entitled “Historiae 
apoplecticorum”, chronic subdural 
hematomas (CSDHs) nowadays represent a 
common intracranial lesion treated in a 
neurosurgical department.  
The elderly population is more frequently 
affected by this condition due to a series of 
predisposing factors, including: increased use 
of antithrombotic medication, vascular 
fragility, larger subdural space and 
susceptibility to frequent mild traumatic 
brain injuries secondary to same-level falls. 
[1]  
The incidence of CSDH is estimated at 1.7 
to 18 per 100 000 people/year and rises to 58 
per 100 000/year in individuals > 65 years of 
age. [2] As the population > 65 years is 
expected to double by 2030, an increase in the 
incidence of CSDH in the coming years is 
also expected. [3] 
Surgical evacuation remains the treatment 
of choice for symptomatic CSDH, with 
several surgical methods including twist drill 
craniotomy or burr hole with drainage, and 
large craniotomy being used. [4,5] Despite its 
high incidence and extensive published 
literature regarding risk factors, management 
and outcome, the optimal surgical strategy as 
well as postoperative management of CSDHs 
continue to attract significant debate.  
Current management of symptomatic 
CSDHs is accompanied by a rather high 
mortality rate, of 13%, which translates into 
approximately 4 deaths a year due to this 
disorder in a typical neurosurgical 
department. [6,7] In spite of rather simple 
operative procedures, the recurrence rate is 
relatively high (up to 33%), as compared with 
other traumatic brain injuries. [8,9] 
Recurrences requiring reoperation (RrR) lead 
to an increase of morbidity and mortality 
rates. They also translate into a prolonged 
hospital length of stay and, implicitly, into 
increased financial costs. [10] 
The aim of the current study was to 
investigate factors predicting RrR in patients 
who underwent surgery for CSDHs in our 
department, in an effort to adjust our 
treatment strategies and consequently 
improve the surgical outcome. 
Material and methods 
We retrospectively reviewed data of 70 
consecutive patients with CSDHs which were 
surgically treated in the Neurosurgery 
Department of “Saint Pantelimon” Clinical 
Emergency Hospital over a period of two 
years, between January 2016 and December 
2017.  
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Patients that, for various reasons, lacked a 
postoperative 24-hour control CT scan were 
excluded from the study, resulting in a total 
number of 64 patients harbouring 71 
surgically treated CSDHs who met de 
inclusion criteria. 
General characteristics 
Patient demographics such as age, sex, 
medical history and risk factors for CSDH 
were recorded.  
The specific risk factors that were taken 
into consideration are represented by alcohol 
abuse and antithrombotic medication. In all 
cases included, any pre-existing antiplatelet 
or anticoagulant therapy was temporarily 
discontinued upon admission and resumed 
after hospital discharge. 
The preoperative Glasgow Coma Scale 
(GCS) score and relevant neurological 
findings were also noted, warranting the 
subsequent choice of surgical management. 
CSDHs were diagnosed by head CT scan 
on the day of admission and subsequently 
confirmed by intraoperative findings. 
Hematomas were grouped into 4 types based 
upon imagistic appearance, as classified by 
Nakaguchi et al. All types included in this 
classification were found in our cohort (Fig. 
1): homogeneous, laminar, separated, and 
trabecular.[11] 
 
Figure 1 - Preoperative CT scans of included patients according to the classification of Nakaguchi et al.: 
homogenous hypodense subtype (A), isodense subtype (B), hyperdense subtype (C); laminar type (D); separated 
type (E), with gradation subtype (F); trabecular type (G) 
 
 
 
 
 
190 | Adam et al - Recurrence of Chronic Subdural Hematomas Requiring Reoperation 
 
 
 
 
 
 
 
The preoperative CT scan findings 
additionally evaluated were: maximum 
hematoma thickness (assessed in mm), 
midline shift, and whether the hematoma was 
uni- or bilateral. In order to determine 
hematoma size in bilateral cases, the 
maximum thickness was considered. 
Surgical management 
All patients underwent surgery under 
general anaesthesia and orotracheal 
intubation. The CSDHs were evacuated using 
two distinct surgical techniques: small 
trephine (25 mm diameter) craniotomy and 5 
or 6 burr-holes bone flap craniotomy.  
In small trephination cases, a 5 – 6 cm 
linear scalp incision was performed, followed 
by a 25 mm craniotomy centred on the 
maximal thickness of the hematoma and a 
star-shaped incision of the underlying dura 
mater. The external membrane of the 
hematoma was opened in a circular fashion, 
preserving a 0.5 cm margin from the 
craniotomy. After hematoma evacuation, this 
margin was coagulated under visual control, 
and retracted as far as the craniotomy 
allowed. The remaining cavity was irrigated 
with warm saline solution in order to 
eliminate any residual blood clots. 
In some cases, a partial inner 
membranectomy was performed, while in 
others it was left intact. An epidural or 
subdural closed-system drainage was placed 
and maintained for at least 24 h. The bone 
flap was repositioned and secured with nylon 
sutures (Fig. 2). 
 
Figure 2 - 1-month postoperative CT reconstruction 
after using the small trephination technique and 
reposition of the bone flap 
 
The operative technique used was chosen 
according to the surgeon’s preference.  In 
cases of bilateral symptomatic CSDHs, the 
operation was performed on both sides in the 
same manner, during the same operative 
session. 
Postoperative management 
A standard procedure was applied in all 
cases: after surgery, the patients were 
transferred from the OR to the ICU for at 
least 24 h for general monitoring, bed rest and 
treatment consisting of intravenous hydration 
with 1000 mL of saline solution and 500 mL 
10% glucose solution. 
Antiepileptic prophylaxis with a single 
loading dose of phenytoin was started during 
surgery; antiepileptic medication was 
continued only in the cases of at least one 
preoperative seizure. Low dose heparin was 
also prophylactically prescribed, in order to 
prevent vascular occlusive events. In cases of 
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pre-existing antiplatelet or anticoagulant 
therapy, medication was resumed after 
discharge, depending on indications.  
Neurological status was constantly 
monitored and logged at least once every day. 
In all cases, follow – up CT scans were 
performed in the first postoperative day, 
comparing residual hematoma thickness and 
midline shift with the preoperative value. 
Recurrence of CSDH requiring 
reoperation was diagnosed when neurological 
status did not improve postoperatively, new 
neurological symptoms occurred or the 
existing ones worsened, and re-accumulation 
of a subdural collection on the operated side 
was visible on follow – up CT scan. 
General outcome (home discharge, 
discharge to another hospital or death in 
hospital), as well as hospital length of stay, 
were also evaluated. 
Statistical Analysis 
Data were described using means 
(standard deviations) and numbers of 
patients (percentages) for continuous and 
categorical variables, respectively. The tests 
were performed using IBM’s SPSS statistical 
analysis software (IBM SPSS v20).  
Univariate and multivariate linear 
regression analyses were performed to assess 
the relationship between risk factors for 
chronic subdural hematomas, preoperative 
hematoma thickness, hematoma 
characteristics based on CT appearance (uni-/ 
bilateral, type of hematoma based on 
Nakaguchi’s classification) and type of 
operation, with RrR.  
In all circumstances a probability (P) value 
of <0.05 was considered statistically 
significant and all tests were 2-tailed. 
Results 
Out of the 64 patients included, 16 
developed recurrence requiring reoperation, 
representing 25% of all cases. 
Patients demographics consisting of sex, 
age, risk factors and GCS score on admission 
are presented in Table 1. 
 
 
Table 1 - General patient characteristics and associated rate of recurrence 
Characteristics 
Total 
no (%) 
Nonrecurrent 
no (%) 
Recurrent 
no (%) 
P-value 
Gender     
 Male 47 (73.44) 33 (70.21) 14 (29.79) .03 
 Female 17 (26.56) 15 (88.24) 2 (13.33)  
Age groups     
 ≥ 65 49 (76.56) 36 (73.44) 13 (26.53) .17 
 < 65 15 (23.44) 12 (80) 3 (20)  
Risk factors     
 Chronic alcohol 
abuse 
29 (45.31) 22 (75,86) 7 (24.14) .05 
 Antiplatelet 14 (21.88) 9 (64.29) 5 (35.71) .41 
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medication 
 Anticoagulant 
medication 
9(14.06) 7 (77.78) 2 (22.22) .98 
Preoperative GCS score     
 3 – 8 12 (18.75) 9 (75) 3 (25) .53 
 9 – 12 8 (12.5) 5 (62.5) 3 (37.5) .61 
 13 -15 44 (68.75) 34 (77.27) 10 (22.73) .40 
 
Out of the 64 patients included in the 
study, 47 (73,44%) were males and 17 
(26.56%) were females, with a male-to-female 
ratio of approximately 2:1. A lower 
recurrence rate was noted among the female 
population, male sex being associated with a 
higher rate of recurrence (p= 0.03) 
A number of 42 patients (65.5%) have 
suffered repeated mild traumatic brain 
injuries before admission, while the rest of the 
patients (34.5%) could not mention notable 
head trauma in the past 3 months. 
Age at presentation varied between 45 and 
89 years, with an average of 69.56 years and a 
considerably high percentage (76.56%) 65 
years old or older, consistent with the 
increased incidence of CSDHs among the 
elderly population. However, age did not 
correlate with recurrence requiring 
reoperation (p=0.17). 
Regarding risk factors for CSDH 
development, previous antiaggregant 
treatment associated an increased, yet not 
statistically significant, rate of hematoma 
recurrence requiring reoperation (p = 0.41). 
Chronic alcohol abuse, although frequently 
encountered among our patients (45.31%), 
did not present a statistically significant 
association with recurrence. 
The leading symptoms at admission were 
headache, dizziness, confusion and motor 
deficit, with an average GCS score of 12. A 
recurrence rate above our overall average can 
be observed in the 9-12 GCS group, although 
not statistically significant (p =0.61). 
Preoperative CT scan identified 7 cases of 
bilateral chronic subdural hematomas, 3 of 
which subsequently required reoperation, 
with a recurrence rate of 42.86%, higher than 
22.81%, associated with the unilateral group, 
but the association did not prove to be 
statistically relevant (p = 0.051, Table 2).
 
Table 2 - CT characteristics of CSDHs and associated rate of recurrence 
Characteristics 
Total 
no (%) 
Nonrecurrent 
no (%) 
Recurrent 
no (%) P-value 
Unilateral 57 (89.06) 44 (77.19) 13 (22.81)  
Bilateral  7 (10.94) 4 (57.14) 3 (42.86) .051 
Maximal thickness     
 ≥ 22 mm 32 (50.00) 18 (56.25) 14 (43.75) .013 
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Maximum hematoma thickness was 
calculated between 9 and 46 mm, with an 
average of 21,75 mm. The selection of cut-off 
values for hematoma thickness was based on 
assessment of ROC curves to find the best 
predictive ability. Regarding the ROC curve 
of thickness ≥ 22 mm, the area under the 
ROC curve was 0.712 (95% CI = [0.584-
0.840], p = 0.013, Fig. 3). A cut-off of 
thickness at 22.50 mm produced a sensitivity 
of 66% and a specificity of 40%. The 
probability of no RrR was estimated to be 
95% if thickness was below 22.50 mm, and 
78% if thickness was above 22.50 mm. 
Regression analysis demonstrated that 
hematoma thickness ≥ 22 mm represented a 
significant predictor for CSDH RrR (p 
=0.013). 
 
Figure 3 - ROC curve of preoperative thickness ≥ 22 
mm 
 
All types of chronic subdural hematomas 
according to the Nakaguchi’s classification 
were encountered in our case series. The 
laminar type was most frequently found (21 
cases), also associating the highest recurrence 
rate (38.10%). It was also the only type of 
hematoma with a statistically significant 
association with recurrence (p=0.027; Table 
2). Homogenous hypo- and hyperdense 
subtypes presented a below average 
reoperation rate, but it was not found to be 
statistically significant (p = 0.78 and p = 0.96 
respectively; Fig. 4). 
 < 22mm 32 (50.00) 30 (93.75) 2 (6.25)  
Type     
 Homogenous hypodense 8 (12,50) 7 (87.50)  1 (12.50) .78 
 Homogenous isodense 8 (12,50) 6 (75.00) 2 (25.00) .82 
 Homogenous hyperdense 5 (7,81) 5 (100.00) 0 (0.00) .96 
 Laminar  21 (32.81) 13 (61.90) 8 (38.10) .027 
 Separated  14 (21,88) 11 (78.57) 3 (21.43) .56 
 Gradation  4 (6,25) 3 (75.00) 1 (25.00) .67 
 Trabecular  4 (6,25) 3 (75.00) 1 (25.00) .73 
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Figure 4 - Rate of recurrence in different types of hematomas according to the Nakaguchi classification 
 
Regarding surgical management, there 
were only 2 types of procedures used for 
hematoma evacuation, depending on the 
surgeon’s preference. The majority (79,69%) 
were operated through a small trephine 
craniotomy. This approach associated a 
recurrence rate of 15,69%, lower than the 
61,54% encountered when a large bone flap 
craniotomy was performed. This result 
proved to be statistically relevant (p =0.008). 
Hematoma inner membrane was partially 
resected in 39% of cases, while in the 
remaining patients it was left intact. 
Reoperation was more often encountered 
after this debatable surgical manoeuvre was 
performed (40% versus 15,38%). 
However, when considering the type of 
approach in association with partial inner 
membranectomy, the least invasive approach 
(trephine without membranectomy) 
presented the lowest recurrence rate 
(14,71%), while the most aggressive one 
(bone flap craniotomy and inner 
membranectomy) presented an unexpectedly 
high recurrence rate (87,5%, Fig. 5). The 
results proved to be statistically significant (p 
= 0.007, Table 3). 
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Figure 5 - Rate of recurrence when considering surgical approach and membranectomy 
 
Table 3 - Type of operation and associated rate of recurrence 
Type of operation 
Total 
no (%) 
Nonrecurrent 
no (%) 
Recurrent 
no (%) 
P-
value 
Small trephine craniotomy 51 (79.69) 43 (84.31) 8 (15.69) .007 
Large bone flap craniotomy 13 (20.31) 5 (38.46) 8 (61.54) .008 
Type of operation ± partial inner membranectomy  
 small trephine craniotomy without membranectomy 34 (53.13) 29 (85.29) 5 (14.71) .52 
 large bone flap craniotomy without membranectomy 5 (7,81) 4 (80.00) 1 (20.00) .43 
 small trephine craniotomy with membranectomy 17 (26.56) 14 (82.35) 3 (17.65) .49 
 large bone flap craniotomy with membranectomy 8 (12.50) 1 (12.50) 7 (87.50) .007 
Type of operation + epidural/ subdural drainage  
 small trephine craniotomy + epidural drain 26 (40.63) 22 (84.61) 4 (15.38) .23 
 large bone flap craniotomy + epidural drain 4 (6.25) 4 (100.00) 0 (0.00) .39 
 small trephine craniotomy + subdural drain 25 (39.06) 21 (84.00) 4 (16.00) .11 
 large bone flap craniotomy + subdural drain 9 (14.06) 1 (11.11) 8 (88.89) .007 
 
Also, evaluating surgical approach 
together with drainage placement, regardless 
of membranectomy, a similar significantly 
high rate of recurrence (88,89%) can be 
observed when associating a large bone flap 
with subdural drainage (p =0.007; Table 3). 
Length of hospital stay varied greatly, 
between 1 and 74 days with an average of 
14,31 days. Patients that were re-operated 
spent on average 22 days in our neurosurgical 
department, almost two times the number of 
days compared with nonrecurrent cases that 
were discharged after an average of 11,58 
days. 
Overall in-hospital mortality was 15,63%, 
slightly higher in the recurrent group 
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(18,75%) compared with the nonrecurrent 
group (14,58%). Causes of death were in all 
cases associated with comorbidities, especially 
previous heart conditions. There was however 
a notable difference regarding number of 
cases that required transfer to another 
department and were not immediately 
discharged home. Also, more cases in the 
recurrent group needed additional medical 
care in neurological or rehabilitation 
departments (Fig. 6). 
 
Fig. 6 - Comparison of outcomes in recurrent and nonrecurrent groups 
 
Discussion  
In 1857, Virchow (1821 – 1902) described 
CSDH as “pachymeningitis haemorrhagica 
interna”. At that time, the condition was 
considered fatal. Over the last 150 years, there 
was a great improvement in outcomes of this 
disorder, mainly due to better understanding 
the pathophysiology, introduction of modern 
imaging, especially the CT scan in the 1970’s, 
and refinement of operative techniques. 
Although a frequently encountered pathology 
in neurosurgery, there has been relatively 
little progress in its management during the 
past 20 years. This is contrasting the 
evolution of concepts and surgical techniques 
in other neurosurgical subspecialties, such as 
functional, spinal, oncologic or vascular 
neurosurgery. [12] 
The poor outcome is directly related to the 
high risk of recurrence requiring reoperation 
associated with CSDHs.  In the last decade, 
many studies have proposed a series of risk 
factors that are associated with an increased 
recurrence rate. 
Relationship between CSDH’s RrR and age. 
There were few sporadic studies that 
suggested a causality relationship between 
advanced age and recur¬rence of CSDHs 
requiring reoperation. [13–15] However, 
most recent studies have demonstrated no 
correlation between advanced age and an 
increased rate of recurrence. [11,16] Also, in 
out cohort of 64 surgically treated patients, 
age over 65 years did not correlate with 
recurrence. 
Advanced age is however a known risk 
factor for the development of CSDH. This 
relationship can be explained by the 
development of cerebral atrophy that is 
associated with aging, as demonstrated by 
 
 
 
 
 
Romanian Neurosurgery (2018) XXXII 2: 187 - 204 | 197 
 
 
 
 
 
 
 
Yang et al in a study published in 2012. [17] 
Yang proved his theory by studying previous 
research regarding the pathogenesis of 
CSDH. Considering CSDH patients, 29 – 38% 
of them have no memorable precipitating 
trauma, unlike acute subdural hematoma 
cases that are almost always preceded by 
compelling trauma. [18] This observation was 
confirmed in our patients, 34% of them 
having no recollection of previous head 
trauma. Most of CSDH patients suffer mild, 
unremarkable trauma, usually with no loss of 
consciousness. [19] Cerebral atrophy enables 
minor stress or trauma to determine 
separation of the dura–arachnoid interface. 
Once these two layers are separated, fibrin, 
from either serum or exudates, can induce 
proliferation of granulation tissue on the 
inner dural surface which leads to formation 
of a neomembrane and consequent growth of 
new vessels directly within the subdural 
space. [20] Subsequent studies have proven 
that CSDHs can develop secondary to 
bleeding from these vessels. [21] It has also 
been stated that atrophy leads to tearing of 
bridging veins between the rigidly fixed dura 
and mobile arachnoid layer. [22] Thus, 
studies assessing the pathogenesis of CSDH 
supported Yang’s hypothesis that patients 
with cerebral atrophy associate a greater risk 
of developing CSDH. 
This connection between cerebral atrophy 
and CSDH contributes to further 
understanding why patients older than 65 
years, who have a higher incidence of brain 
atrophy present an increased risk for CSDH 
development. [23] The results of our study 
support Yang’s theory, when considering that 
more than 70% of patients included were over 
65 years. 
Relationship between CSDH’s RrR and 
alcoholism 
The Framingham Heart Study 
demonstrated an important correlation 
between alcoholism and cerebral atrophy. 
[24] The results suggested that cerebral 
atrophy may be one characteristic feature of 
alcoholic patients and thus is a risk factor for 
CSDH development. [18] In this study, a 
significant number of subjects presented 
chronic alcohol abuse (45,31%). However, the 
rate of recurrence requiring surgery for these 
patients is similar to the general overall 
reoperation rate. 
The fact that a considerable proportion of 
the included patients were represented by 
elders and chronic alcoholics merely supports 
results from previous studies, advanced age 
and alcohol abuse representing risk factors 
for the development of chronic subdural 
hematoma, not for its recurrence. 
Relationship between CSDH’s RrR and 
antithrombotic medication 
The significantly higher prevalence of 
chronic subdural hematoma among the 
elderly could also be partially explained by the 
fact that 41% of them take antithrombotic 
medication, usually prescribed for prevention 
or treatment of coronary artery disease.[25] 
Nevertheless, CSDH patients under 
antiplatelet or anticoagulant therapy can pose 
a serious challenge for the neurosurgeon, 
generally associating a greater risk of intra- 
and postoperative bleeding. 
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Despite the absence of a definitive 
protocol, most neurosurgeons prefer to 
preoperatively discontinue and substitute 
antithrombotic therapy. Once discontinued 
however, the optimal timing for operation, as 
well as for resuming antithrombotic 
medication is unclear. Decision making 
remains a challenge: there is an unknown risk 
of intracranial re-bleeding when therapy is 
restarted too early and, simultaneously, a 
constant risk of vascular thrombotic events 
under suboptimal anticoagulation. 
In our study, 35,9% of patients were under 
antithrombotic or anticoagulant medication 
which, in all cases, was discontinued and 
replaced with low dose heparin before 
surgery. Patients were operated after a 
variable interval, from a few hours up to 10 
days, depending on the neurological status 
and associated conditions necessitating 
antithrombotic medication. Antithrombotic 
medication was not resumed during 
hospitalization in the neurosurgical 
department in any of the aforementioned 
cases. This decision was made in accordance 
with recommendations in published 
literature. [26] Concerning recurrence 
requiring reoperation in these patients, we 
found a higher recurrence rate in cases with 
antiplatelet treatment (37,5%), by comparison 
with the overall rate (25%). 
Relationship between CSDH’s RrR and CT 
characteristics 
CT scanning of patients with CSDH 
provides a significant amount of information 
regarding the intracranial status and remains 
the most important diagnostic investigation 
for this disorder. Numerous CT 
characteristics traditionally related to CSDH 
recurrence have been reported and widely 
debated in the literature. These included 
bilateral site of CSDH, preoperative and 
postoperative haematoma thickness or 
volume, preoperative and postoperative 
midline shift, haematoma densities, 
postoperative presence of air in the CSDH 
cavity, and postoperative persistence of 
residual CSDH space. [18,27,28] However, 
the influence of these CT features on outcome 
was not consistent between studies. 
Therefore, we evaluated possible 
associations between the radiological 
characteristics of chronic subdural 
hematomas and their recurrence rate in our 
series. The imaging appearance of CSDHs 
based on the density changes was assessed 
using the classification described by 
Nakaguchi et al. into four types: the 
homogeneous (including hypodense, 
isodense, and hyperdense subtypes), laminar, 
separated (including gradation subtype) and 
trabecular.11 We also evaluated if chronic 
subdural hematomas were uni- or bilateral, 
the pre-and postoperative hematoma 
thickness, as well as midline shift. 
We found only two significant predictors 
for postoperative recurrence: laminar type 
and preoperative haematoma thickness > 22 
mm. 
Isodense, hyperdense, laminar and 
separated appearances are considered to have 
a greater tendency towards re-bleeding due to 
a greater vascularity, compared to 
homogenous types. [11,29] Our data 
suggested that the laminar type was an 
important predictor of postoperative 
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recurrence, associating a rate of 38,10%, 
significantly higher than the overall 
recurrence rate in our cohort (25%). The 
other types of hematoma: homogenous, 
separated and trabecular, presented similar 
associated recurrence rates. These findings 
generally correspond with some results 
reported in literature. In 2001, Mori et al. 
reported the outcome of 500 patients with 
surgically treated CSDH and did not find a 
positive correlation between CT densities of 
hematomas and the rate of recurrence. [18] 
More recent studies however have different 
results. In 2017, Stanisic et al  proposed a 
grading system for prediction of chronic 
subdural hematoma recurrence requiring 
reoperation called the Oslo score, 2 of the 5 
maximum possible points being attributed for 
certain types of the Nakaguchi classification 
(laminar, separated, isodense and 
hyperdense). [30] 
In our study we found a much higher 
reoperation rate (42,86%) associated to 
bilateral chronic subdural hematomas, 
compared to the overall 25%. The fact that 
bilateral CSDHs associate a much higher 
recurrence rate compared to unilateral ones 
has been confirmed by numerous other 
studies. Torihashi et al. reviewed 343 cases of 
CSDH, including 61 patients who had a 
recurrence and his analyses showed that a 
bilateral CSDH was an independent predictor 
for the recurrence of CSDH. [31] The 
correlation seems to be caused by poor brain 
re-expansion that creates the potential for 
recurrence of the hematoma. [14] 
There are numerous reports that evaluated 
the preoperative volume of CSDH on CT scan 
as a prognostic factor for recurrence. It was 
included in the Oslo score, which considered 
that a preoperative hematoma volume greater 
than 130 mL has a significant impact on 
recurrence. In our study, we evaluated 
preoperative maximal hematoma thickness 
on CT scan, a characteristic much less 
discussed in the literature compared to 
preoperative volume, but readily available in 
our standard radiological reports. We found 
that a preoperative hematoma thickness > 22 
mm associated a recurrence rate of 43,75%, in 
great contrast with a rate of only 6,25% when 
thickness was lower than 22 mm. Based on 
this difference, it appears that preoperative 
hematoma thickness greatly influences the 
recurrence rate. 
Relationship between CSDH’s RrR and type 
of operation 
The treatment of CSDH is an extremely 
debated topic. In 1925, Putnam and Cushing 
suggested craniotomy and removal of the 
outer membrane as a treatment option. [32] 
For many years craniotomy has been accepted 
as the optimal technique in the treatment of 
CSDH despite the high associated surgical 
mortality rate of 30%. Nowadays however, the 
following techniques have been adopted 
world-wide for CSDH management: (1) two 
burr holes and irrigation; (2) single “large” 
burr hole with irrigation and aspiration; (3) 
single burr hole with placement of a subdural 
drain, maintained 24-48 hours, (4) twist drill 
craniotomy with aspirative drainge and (5) 
large craniotomy with excision of the 
subdural membrane. [33,34] 
Lega et al. performed in 2009 a “Medline 
search on articles published between January 
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1966 and September 2006 about CSDHs and 
made a decision analysis”. They suggested 
that burr hole craniotomy is superior to twist-
drill craniotomy and large craniotomy in 
treating CSDHs. [35] Regan et al. compared 
burr hole craniotomy and large craniotomy, 
proving the superiority of the latter technique 
when considering reoperation rates [36] Also, 
Williams et al. compared burr hole and twist 
drill craniotomy and found a much higher 
reoperation rate (64%) associated to the latter 
procedure and only 11 % reoperation rate 
associated with burr hole craniotomy. [37] 
The 64 patients included in the study were 
operated using two main types of surgical 
approaches: small trephination applied for 
the majority of the patients (79%), and large 
craniotomy used in the rest of the cases 
(20,31%). When strictly considering the type 
of the approach, the recurrence rate was 
significantly higher in cases where a large 
craniotomy was performed (61,54%), 
compared to 15,69%, the recurrence rate 
associated to small trephine craniotomy. 
Another systematically discussed topic 
throughout the literature is the necessity of 
internal membranectomy after hematoma 
evacuation and whether its resection has any 
influence upon the recurrence rates. Many 
authors have addressed this issue but the 
conclusions were not altogether consistent, 
some favouring membranectomy, while 
others regarding it as a main prognostic 
factor for recurrence. 
Lee et al compared three different primary 
surgical methods (burr-holes, enlarged and 
extended craniectomy with partial 
membranectomy) in 172 patients with CSDH. 
The rate of re-operation was 16% in the group 
of burr-hole drainage, whereas it was 18% 
and 23% in partial membranectomy with 
enlarged and extended craniectomy, 
respectively.16 Also, Khadka et al. reported 
favourable outcome in 98.6% of 365 patients 
who underwent single burr-hole drainage, 
with no membranectomy. [38] On the other 
hand, Kim et al. compared a group of 16 
patients who underwent a small craniotomy 
and another group of 42 patients who 
underwent a large craniotomy, with partial 
and extended membranectomy respectively. 
They concluded that the large craniotomy 
with extended membranectomy reduced the 
re-operation rate, compared with the small 
craniotomy group. [39] 
In our cohort, there were 25 cases 
(39,06%) in which a partial internal 
membranectomy was performed, in the rest 
of the cases the inner membrane being left 
intact (60,94%). Membrane incision was 
associated with a significantly increased 
recurrence rate (40% versus 15,38%). This 
rate was even higher when associating a large 
craniotomy with inner membranectomy 
(RrR=87,5%). A cause for this high 
recurrence rate after operated CSDH via this 
technique could be the fragile sinusoidal 
vessels that are present at the junction of 
inner and outer membranes which had not 
been adequately coagulated, provoking 
repeated multifocal hemorrhages. [40] 
Another reason could be stretching and 
rupturing of bridging veins entering the 
superior sagittal sinus once brain begins to re-
expand. [39] Similar results were encountered 
in Balevi’s cohort which included 148 patients 
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with surgically treated CSDH’s, 28 of them 
being operated by large craniotomy with 
inner membrane excision. [41] The latter 
group associated a recurrence rate of 28.5%, 
while the reported rate associated to burr hole 
drainage is 4%–8%. [42] Given the high 
recurrence rate associated with inner 
membranectomy that we observed, we do not 
recommend performing this surgical 
manoeuvre. 
„To drain or not to drain?” is a disputed 
question to which Santarius et al provided an 
answer in the Lancet in 2008. They conducted 
a randomized controlled trial in which 
patients with CSDH were assigned to receive 
a subdural drain or no drain after evacuation. 
Surprisingly enough, the trial was ended 
prematurely due to a significant reduction of 
recurrence, morbidity, and mortality at 6 
months in patients receiving a drain. 
Recurrence occurred in 10 of 108 (9.3%) 
patients with a drain, and 26 of 107 (24%) 
without. [3] 
In our cohort, a drain was placed in all 
cases, with a variation regarding its position: 
epidurally or subdurally. We did not find a 
significant difference regarding recurrence 
rate when comparing epidural with subdural 
drainage following small trephine craniotomy 
(15,38% versus 16%, respectively). The results 
are similar to the ones presented by 
Kaliaperumal et al. They compared two types 
of drainage, subperiosteal drainage and 
subdural drainage following bur hole, in a 
cohort of 50 patients with operated CSDH, 
detecting no significant differences between 
recurrence rates. [43] Concerning the 
considerably more aggressive technique, we 
found an increase of recurrence rate when 
associating large craniotomy with subdural 
drain (88,89%).  
As a result of a literature data review, it 
appears that there is a great diversity 
regarding approaches for CSDHs, varying 
from small, less invasive techniques (twist 
drill, burr hole) to large sized, more 
aggressive ones (bone flap). The trephination 
method that we currently practice can be 
adequately considered an intermediate 
technique between the two extremes, clearly 
leaning towards the less invasive category. 
When considering small sized approaches, 
burr hole and small trephine craniotomies are 
very similar regarding recurrence rates. The 
exception from this category is the twist drill 
craniotomy which usually associates higher 
reoperation rates. 
Small trephine craniotomy, with a 25 mm 
diameter, offers a good operative field in 
order to coagulate the external hematoma 
membrane, as well as the possibility to easily 
aspirate hematoma content, especially in the 
trabecular type cases where septa could 
prevent complete evacuation, or in the cases 
where hematoma content is not completely 
liquefied. Another advantage consists in the 
possibility to easily reposition the bone flap, 
thus avoiding any poor cosmetic results, 
regardless of trephine positioning. 
Amongst the two extremes represented by 
small (burr hole, twist drill) and large 
craniotomies, the approach that we use (small 
sized trephination) could be considered a 
valid alternative in CSDH surgery. 
 
 
 
 
 
 
202 | Adam et al - Recurrence of Chronic Subdural Hematomas Requiring Reoperation 
 
 
 
 
 
 
 
Limitations 
This is a retrospective, single-centre study 
so it presents certain limitations and the 
results presented should be interpreted 
accordingly. The number of patients is small 
despite the relatively long inclusion period 
and high incidence of operated CSDH in a 
typical neurosurgical department. No 
member of our Neurosurgical Department 
used the burr hole or twist drill techniques so, 
unfortunately, we could not compare it to our 
small trephination. There were a few patients 
excluded due to lack of postoperative imaging 
studies. Also, the surgical interventions were 
performed by different neurosurgeons 
included in our department, each with certain 
unquantifiable particularities regarding 
technique. 
Conclusions 
Certain CT characteristics of chronic 
subdural hematomas associate a significantly 
higher rate of recurrence: laminar type and 
increased thickness (>22 mm). Nevertheless, 
these are nonmodifiable factors.  
In our series, surgical technique had a 
decisive impact on the rate of recurrence. 
While some surgeons might still argue in 
favour of large bone flap craniotomies, 
subdural drainage and / or membranectomy, 
their negative influence on the rate of 
recurrence is undeniable. CSDH surgery is 
another example of “in medio stat virtus”, 
where finding the right balance between the 
least and most aggressive technique has the 
potential of providing the best outcomes, and 
thus small trephination could be taken into 
consideration. 
Ethical approval 
All procedures performed in studies 
involving human participants were in 
accordance with the ethical standards of the 
institutional and/or national research 
committee and with the 1964 Helsinki 
declaration and its later amendments or 
comparable ethical standards. For this type of 
study formal consent is not required. 
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